颈椎硬膜外神经阻滞治疗颈源性心律失常的临床研究  

Clinical study of cervical epidural block for the treatment of thepatients with cervicogenic arrhythmia

作　　者：乔长峰[1] 王莹[1] 杨振玲[1] 陈景涛[1] 张学良[1] 

机构地区：[1]河南大学第一附属医院,河南开封475000

出　　处：《河南大学学报（医学版）》2016年第2期110-113,共4页Journal of Henan University:Medical Science

基　　金：河南大学科研基金项目(2012YBZR022)

摘　　要：〔目的〕研究CT引导下硬膜外神经阻滞治疗颈源性心律失常的治疗效果。〔方法〕将96例颈源性心律失常患者随机分为A组(神经阻滞治疗组)和B组(对照组),每组48例,一般临床资料无差异。A组患者行颈部硬膜外神经阻滞治疗,并每天静脉注射牛痘疫苗致炎兔皮提取物7.2 U和甲钴胺注射液1 mg,共14 d;B组患者每天静脉注射牛痘疫苗致炎兔皮提取物7.2 U和甲钴胺注射液1 mg,共14 d。两组患者分别在治疗前及结束后1 mon和6 mon时行VAS评分,记录评价治疗效果。〔结果〕在结束治疗1 mon和6 mon时,A组患者颈部疼痛VAS评分明显下降(3.5±1.1,3.7±1.8),低于B组(5.2±1.7,5.4±1.3),P<0.05;A组患者治疗总有效率达到93.75%,高于B组(66.67%),P<0.05。〔结论〕CT引导下颈部硬膜外治疗颈源性心律失常临床治疗效果好,值得推广应用。〔Objective〕To investigate the effect of Gemstone Spectral CT guided cervical epidural block for the patients with cervicogenic arrhythmia.〔Methods〕The study was examinated and approved by the hospital ethics committee. 96 patients signed the informed consent and were randomly divided into Groups A, B. These differences in general clinical data were neither statistically nor clinically significant. The patients of group A received the treatments of ervical epidural nerve block every one week 3 continuous week and Neurotropin 7.2 U, mecobalamin injection by intravenous injection everyday, a total of 14 days; The patients of group B only received the treatments of Neurotropin 7.2 U, mecobalamin injection by intravenous injection everyday, a total of 14 days; VAS score for the patients were observed, scored before treatment and after 1 month and 6 months. Clinical symptoms score for the patients were observed, scored after 1 month and 6 months.〔Results〕The VAS and total effective rate of group A were 3.7±1.8, 93.75% after treatment,which had significant difference with group B（ 5. 2 ± 1. 7, 66. 67%）, P 0.05.〔Conclusion〕the effect of Gemstone Spectral CT guided cervical epidural block for the patients with cervicogenic arrhythmia is better and worth spreading clinically.

关 键 词：地塞米松 脂质体 硬膜外 注射 心律失常 颈椎病 CT引导下 

分 类 号：R45[医药卫生—治疗学]